Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease

Leishmaniasis affects approximately 2 million people each year throughout the world. This high incidence is due in part to the lack of an efficacious vaccine. We present evidence that the recombinant leishmanial antigens LmSTI1 and TSA, which we identified and characterized previously, induce excell...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Campos-Neto, Antonio, Porrozzi, Renato, Greeson, Kay, Coler, Rhea N., Webb, John R., Seiky, Yasir A. W., Reed, Steven G., Grimaldi, Gabriel
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2001
Sujets:
Fungal and Parasitic Infections
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC98475/
https://ncbi.nlm.nih.gov/pubmed/11349082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.6.4103-4108.2001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires